• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全离体末期肝脏中肝细胞癌的多中心发生和扩散。

Multicentric occurrence and spread of hepatocellular carcinoma in whole explanted end-stage liver.

机构信息

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

出版信息

Hepatol Res. 2009 Feb;39(2):143-8. doi: 10.1111/j.1872-034X.2008.00443.x. Epub 2008 Nov 25.

DOI:10.1111/j.1872-034X.2008.00443.x
PMID:19054149
Abstract

AIM

Hepatocellular carcinoma (HCC) arising from the end stages of liver cirrhosis is a fair indication for liver transplantation (LT). To pathologically investigate the multicentric occurrence of relatively early staged HCC in cirrhosis, we studied whole explanted livers.

METHODS

Fourteen explanted livers from patients undergoing living donor LT (LDLT) were examined. The stage of the HCCs was judged to be within the Milan criteria (M-C; a single HCC less than 5 cm or three HCCs less than 3 cm). Histological examination was performed using serially sectioned specimens 5-7 mm in width. Characterization of preoperatively detectable and undetectable lesions was also performed.

RESULTS

In nine patients (64.3%), a total of 34 nodules were found after whole liver histological examination (WLHE). In five patients (31%), the results exceeded the M-C. The characteristics of undetectable HCCs included a minute (median size 6 mm), well-differentiated appearance (80%), with indistinct margins (85.3%) and without vascular invasion (94%). There was no recurrence in any patients at the time of follow up (median follow-up period, 30.1 months).

CONCLUSION

A multicentric occurrence of HCCs was demonstrated in cirrhotic livers with HCCs within the M-C. Undetectable HCCs in cirrhotic livers may have no impact on recurrence after LT.

摘要

目的

源于肝硬化终末期的肝细胞癌(HCC)是肝移植(LT)的合理适应证。为了从病理上研究肝硬化中相对早期阶段 HCC 的多中心发生,我们研究了整个切除的肝脏。

方法

研究了 14 例接受活体供体 LT(LDLT)的患者的 14 个切除肝脏。HCC 的分期被判断为符合米兰标准(M-C;单个 HCC 小于 5 厘米或三个 HCC 小于 3 厘米)。使用 5-7 毫米宽的连续切片标本进行组织学检查。还对术前可检测和不可检测病变进行了特征描述。

结果

在 9 名患者(64.3%)中,在进行全肝组织学检查(WLHE)后总共发现了 34 个结节。在 5 名患者(31%)中,结果超出了 M-C。不可检测 HCC 的特征包括微小(中位大小 6 毫米)、分化良好(80%)、边界模糊(85.3%)且无血管侵犯(94%)。在随访期间(中位随访时间为 30.1 个月),没有任何患者复发。

结论

在符合 M-C 的肝硬化肝脏中证明了 HCC 的多中心发生。肝硬化中不可检测的 HCC 可能对 LT 后复发没有影响。

相似文献

1
Multicentric occurrence and spread of hepatocellular carcinoma in whole explanted end-stage liver.全离体末期肝脏中肝细胞癌的多中心发生和扩散。
Hepatol Res. 2009 Feb;39(2):143-8. doi: 10.1111/j.1872-034X.2008.00443.x. Epub 2008 Nov 25.
2
Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.肝硬化合并小肝细胞癌患者的肝移植:术前影像学、切除标本组织学及预后组织学指标分析
Dig Surg. 2004;21(2):152-9; discussion 159-60. doi: 10.1159/000078741. Epub 2004 May 27.
3
The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver.在切除的肝硬化肝脏中,通过钆塞酸二钠增强磁共振成像(Gd-EOB-MRI)检测到不可见的肝细胞癌中转运体OATP2/OATP8的表达降低。
Hepatol Int. 2013 Jun;7(2):655-61. doi: 10.1007/s12072-012-9379-y. Epub 2012 Jun 24.
4
Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.肝细胞癌:在肝硬化切除肝脏中偶然发现。
Transplant Proc. 2005 Jul-Aug;37(6):2791-2. doi: 10.1016/j.transproceed.2005.07.014.
5
Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran.103例乙肝相关肝硬化肝移植肝脏中的肝细胞癌及其癌前病变:来自伊朗南部的一项研究
Hepat Mon. 2016 Jul 20;16(8):e38584. doi: 10.5812/hepatmon.38584. eCollection 2016 Aug.
6
Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.发育异常结节与肝细胞癌:移植肝硬化肝脏的薄层磁共振成像与病理对照
Radiology. 1996 Oct;201(1):207-14. doi: 10.1148/radiology.201.1.8816545.
7
Pathological study on multicentric occurrence of hepatocellular carcinoma.肝细胞癌多中心发生的病理学研究
Kurume Med J. 2005;52(4):133-8. doi: 10.2739/kurumemedj.52.133.
8
Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers.磷脂酰肌醇蛋白聚糖3、热休克蛋白70和谷氨酰胺合成酶在肝硬化和非肝硬化肝脏发生的肝细胞癌中的诊断价值
J Clin Exp Hepatol. 2018 Jun;8(2):173-180. doi: 10.1016/j.jceh.2017.09.005. Epub 2017 Oct 7.
9
E-cadherin expression in hepatocellular carcinoma treated with previous local treatment in patients undergoing living donor liver transplantation.接受活体肝移植患者中,先前接受局部治疗的肝细胞癌组织中E-钙黏蛋白的表达情况
Transplant Proc. 2015 Apr;47(3):700-2. doi: 10.1016/j.transproceed.2015.02.017.
10
[Liver transplantation in patients with hepatocellular carcinoma].[肝细胞癌患者的肝移植]
Korean J Gastroenterol. 2010 Jun;55(6):350-60. doi: 10.4166/kjg.2010.55.6.350.

引用本文的文献

1
Serum wisteria floribunda agglutinin-positive human Mac-2 binding protein is unsuitable as a diagnostic marker of occult hepatocellular carcinoma in end-stage liver cirrhosis.血清槐凝集素阳性人 Mac-2 结合蛋白不适合作为终末期肝硬化隐匿性肝细胞癌的诊断标志物。
PLoS One. 2023 Nov 1;18(11):e0293593. doi: 10.1371/journal.pone.0293593. eCollection 2023.
2
Long-term outcomes of living-donor liver transplantation, hepatic resection, and local therapy for hepatocellular carcinoma with three <3-cm nodules in a single institute.单中心中对具有三个<3cm结节的肝细胞癌进行活体肝移植、肝切除及局部治疗的长期结果
JGH Open. 2022 Jun 30;6(8):539-546. doi: 10.1002/jgh3.12783. eCollection 2022 Aug.
3
The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver.
在切除的肝硬化肝脏中,通过钆塞酸二钠增强磁共振成像(Gd-EOB-MRI)检测到不可见的肝细胞癌中转运体OATP2/OATP8的表达降低。
Hepatol Int. 2013 Jun;7(2):655-61. doi: 10.1007/s12072-012-9379-y. Epub 2012 Jun 24.
4
Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.预测肝细胞癌组织学微血管侵犯的因素:229 例根治性肝切除病例的经验教训。
World J Surg. 2010 May;34(5):1034-8. doi: 10.1007/s00268-010-0424-5.
5
Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantation.移植前治疗对肝细胞癌的实际治疗效果及其对挽救性活体肝移植术后生存的影响。
J Gastroenterol. 2009;44(6):624-9. doi: 10.1007/s00535-009-0043-9. Epub 2009 Apr 21.